Second Amendment to License AgreementLicense Agreement • March 23rd, 2020 • AC Immune SA • Pharmaceutical preparations
Contract Type FiledMarch 23rd, 2020 Company IndustryThis Second Amendment to License Agreement (the “Amendment”) is made and entered into as of March 20, 2020, by and between AC Immune SA, a Swiss Company (“ACI”) and Eli Lilly and Company, an Indiana Corporation (“Lilly”). (As used herein ACI and Lilly may be individually referred to as a “Party” and collectively referred to as the “Parties”).